Sulbactam-durlobactam for infections caused by Acinetobacter baumannii-calcoaceticus complex

Lancet Infect Dis. 2023 Aug;23(8):e274. doi: 10.1016/S1473-3099(23)00422-X. Epub 2023 Jul 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acinetobacter baumannii*
  • Anti-Bacterial Agents / therapeutic use
  • Azabicyclo Compounds
  • Humans
  • Microbial Sensitivity Tests
  • Sulbactam / therapeutic use

Substances

  • sulbactam-durlobactam
  • Sulbactam
  • Anti-Bacterial Agents
  • Azabicyclo Compounds